↓ Skip to main content

Economic Evaluation of Third-Line Treatment with Alemtuzumab for Chronic Lymphocytic Leukaemia

Overview of attention for article published in Clinical Drug Investigation, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

policy
1 policy source

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
24 Mendeley